Prosztatarák: vizsgálatok itt: Hongkong

In Hongkong 28 Also abroad 1481

28 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

No phaseTaking people
A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer: The VIOLETTA Trial
Where
Shatin
Életkor
50 év and over
People
110
Run by
Chinese University of Hong Kong
See details and how to joinNCT06262633
No phaseTaking people
WATER IV PCa (AS Sub-study)
Where
Shatin
Életkor
45 év and over
People
333 worldwide
Run by
PROCEPT BioRobotics
See details and how to joinNCT07650448
3. fázisTaking people
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Where
Hong Kong, Shatin
Életkor
18 év and over
People
1310 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00
No phaseTaking people
Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection
Where
Hong Kong
Életkor
18 év and over
People
510
Run by
Chinese University of Hong Kong
See details and how to joinNCT05443412
No phaseTaking people
To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence
Where
Hong Kong
Életkor
18 év and over
People
629
Run by
Chinese University of Hong Kong
See details and how to joinNCT06360523
No phaseTaking people
The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy
Where
Hong Kong
Életkor
18 év to 85 év
People
100 worldwide
Run by
The University of Hong Kong
See details and how to joinNCT06740071
3. fázisTaking people
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Where
Hong Kong, New Territories
Életkor
18 év and over
People
1440 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00
No phaseTaking people
The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT
Where
Hong Kong
Életkor
18 év and over
People
300
Run by
Chinese University of Hong Kong
See details and how to joinNCT06163924
No phaseTaking people
The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population
Where
Shatin
Életkor
18 év and over
People
10 000
Run by
Chinese University of Hong Kong
See details and how to joinNCT03893929
No phaseTaking people
To Identify Potential New Urine Markers for the Screening of Prostate Cancer
Where
Shatin
Életkor
18 év and over
People
10 000
Run by
Chinese University of Hong Kong
See details and how to joinNCT03914391
No phaseTaking people
Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial
Where
Hong Kong
Életkor
18 év and over
People
1620
Run by
Chinese University of Hong Kong
See details and how to joinNCT06303622
No phaseTaking people
Prostate Irreversible Electroporation Study
Where
Hong Kong
Életkor
40 év to 85 év
People
10
Run by
Chinese University of Hong Kong
See details and how to joinNCT06886321
No phaseTaking people
The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI
Where
Hong Kong
Életkor
18 év and over
People
250
Run by
Chinese University of Hong Kong
See details and how to joinNCT07386496
3. fázisTaking people
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Where
Chai Wan
Életkor
18 év and over
People
1500 worldwide
Run by
NRG Oncology
See details and how to joinNCT05946213
No phaseTaking people
Hong Kong Prostate Cancer Study Group Database
Where
Shatin
Életkor
18 év and over
People
15 000
Run by
Chinese University of Hong Kong
See details and how to joinNCT03344835
No phaseTaking people
The Effect of Pulsed Electromagnetic Field Therapy on Muscle Mass and Muscle Strength in Prostate Cancer Patients Treated With Androgen Deprivation Therapy
Where
Shatin
Életkor
18 év and over
People
110
Run by
Chinese University of Hong Kong
See details and how to joinNCT07057375
No phaseNot yet taking people in Hongkong
Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI Utilization
Where
Hong Kong, Sheung Shui
Életkor
45 év and over
People
400
Run by
Chinese University of Hong Kong
See details and how to joinNCT07760857
3. fázisTaking people
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Where
Central, Hong Kong
Életkor
18 év and over
People
1314 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06136650 · EU 2023-504957-11-00
3. fázisTaking people
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Where
Hong Kong
Életkor
18 év to 100 év
People
940 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06855277
3. fázisTaking people
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
Where
Hong Kong
Életkor
18 év and over
People
1330 worldwide
Run by
AstraZeneca
See details and how to joinNCT07711002 · EU 2026-526275-38-00
2. fázisTaking people
A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation Therapy (ADT)
Where
Shatin
Életkor
18 év and over
People
54
Run by
Chinese University of Hong Kong
See details and how to joinNCT07568236
1. fázisTaking people
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Where
Hong Kong
Életkor
18 év and over
People
180 worldwide
Run by
Olema Pharmaceuticals, Inc.
See details and how to joinNCT06784193
1/2. fázisTaking people
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Where
Hong Kong
Életkor
18 év and over
People
181 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07190300 · EU 2025-521873-15-00
2/3. fázisTaking people
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Where
Hong Kong
Életkor
18 év to 100 év
People
443 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06780670 · EU 2024-512342-42-00
No phaseTaking people
Registry for Prostate Cancer Focal Therapy
Where
Hong Kong
Életkor
18 év and over
People
200
Run by
The University of Hong Kong
See details and how to joinNCT07792590